Potentiation of radioimmunotherapy with response-selective peptide agonist of human C5a

Journal of Nuclear Medicine

Volumn 43, Issue 7, 2002, Pages 957-967

  Kurizaki, Takashi ^a   Okazaki, Shinji ^a   Sanderson, Sam D ^a   Colcher, David ^a   Enke, Charles A ^a   Tempero, Margaret A ^a   Baranowska Kortylewicz, Janina ^a  

^a J Bruce Henriksen Laboratories   (United States)

Author keywords

Adenocarcinoma; C5a agonist; Radioimmunotherapy; Tumor uptake; Vascular permeability

Indexed keywords

IMMUNOLOGIC AGENT; IODINE 131; MONOCLONAL ANTIBODY B.72.3; PEPTIDE AGONIST OF HUMAN C5A; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; COLORECTAL CANCER; CONTROLLED STUDY; DOSE RESPONSE; DRUG DISTRIBUTION; DRUG POTENTIATION; DRUG UPTAKE; FEMALE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; RADIOIMMUNOTHERAPY; TUMOR GROWTH; TUMOR REGRESSION;

ADENOCARCINOMA; ANIMALS; COMPLEMENT C5A; FEMALE; HUMANS; IODINE RADIOISOTOPES; MICE; MICE, INBRED C57BL; MICE, NUDE; RADIOIMMUNOTHERAPY; TISSUE DISTRIBUTION; TRANSPLANTATION, HETEROLOGOUS;

EID: 0036301413     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. The presence of a concomitant bulky tumor can decrease the uptake and therapeutic efficacy of radiolabeled antibodies in small tumors
2. Uptake of indium-111-labeled monoclonal antibody ZME-018 as a function of tumor size in a patient with melanoma
3. 131I-Lym-1 pharmacokinetics and radiation dosimetry in patients with non-Hodgkin's lymphoma and chronic lymphocytic leukemia
4. Antibodies in the therapy of colon cancer
5. The impact of tumor size on the efficacy of monoclonal antibody-targeted radiotherapy: Studies using a nude mouse model with human renal cell carcinoma xenografts
6. Experimental approaches to increase radiolabeled antibody localization in tumors
7. The biologic window for chimeric L6 radioimmunotherapy
8. Physiological factors influencing radioantibody uptake: A study of four human colonic carcinomas
9. Enhancement of monoclonal antibody uptake in human colon tumor xenografts following irradiation
10. Enhanced delivery of a monoclonal antibody F(ab)2 fragment to subcutaneous human glioma xenografts using local hyperthermia
11. Pharmacologic intervention with angiotensin 11 and kininase inhibitor enhanced efficacy of radioimmunotherapy in human colon cancer xenografts
12. Identification of a monoclonal antibody, TV-1, directed against the basement membrane of tumor vessels, and its use to enhance the delivery of macromolecules to tumors after conjugation with interleukin-2
13. Tumor-necrosis factor can enhance radio-antibody uptake in human colon carcinoma xenografts by increasing vascular permeability
14. Neovascular targeting with cyclic RGD peptide (cRGDf-ACHA) to enhance delivery of radioimmunotherapy
15. Biochemistry and biology of anaphylatoxins
16. Primary structure and functional characterization of rat C5a: An anaphylatoxin with unusually high potency
17. Decapeptide agonists of human C5a: The relationship between conformation and neutrophil response
18. Decapeptide agonists of human C5a: The relationship between conformation and spasmogenic and platelet aggregatory activities
19. Conformationally biased analogs of human C5a mediate changes in vascular permeability
20. Response-selective C5a agonists: Differential effects of neutropenia and hypotension in the rat
21. Analysis of a human tumor-associated glycoprotein (TAG-72) identified by monoclonal antibody B72.3
22. Molecular adjuvant effects of a conformationally biased agonist of human C5a anaphylatoxin
23. Radioimmunotherapy of human colon cancer xenografts using a dimeric single-chain Fv antibody construct
24. Patient-specific dosimetry of indium-111- and yttrium-90-labeled monoclonal antibody CC49
25. 90yttrium-labeled monoclonal antibody CC49: A phase 1 trial
26. High-dose therapy with iodine-131-labeled monoclonal antibody CC49 in patients with gastrointestinal cancers: A phase I trial
27. Distribution of oncofetal antigen tumor-associated glycoprotein-72 defined by monoclonal antibody B72.3
28. Reactivity of B72.3 with adenocarcinomas
29. Localization by whole-body autoradiography of intact and fragmented radiolabeled antibodies in metastatic colonic cancer model
30. Quantitative and qualitative effects of experimental radioimmunotherapy on tumor vascular permeability
31. A recombinant single chain antibody interleukin-2 fusion protein
32. Radiolabeled interleukin-8: Specific scintigraphic detection of infection within a few hours
33. Capillary permeability of two transplantable rat turnouts as compared to various normal organs of the rat